RIPK1 and metabolic dysfunction-associated steatohepatitis: However, in CD-HFD-induced NASH, hepatocyte-specific loss of UGDH exaggerates NASH-associated liver damage and fibrosis by promoting hepatocyte apoptosis, which is ameliorated by RIPK1-D138N mutation.